Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Microcephalic primordial dwarfism, Dauber type is a rare, genetic developmental defect during embryogenesis characterized by severe pre- and postnatal growth retardation, severe microcephaly, severe developmental delay and intelletual disability, severe adult short stature and facial dysmorphism (incl. hypotelorism, small ears, prominent nose). Other reported features include skeletal anomalies (Madelung deformity, clinodactyly, mild lumbar scoliosis, bilateral hip dysplasia) and seizures. Absence of thelarche and menarche is also associated.
Features include always present findings: Severe short stature, Hip dysplasia, Microcephaly, and Hypoplasia of the uterus and others; and common findings: Short middle phalanx of the 5th finger.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 3 | Seizure, Severe global developmental delay, Severe intellectual disability |
NIN encodes ninein (2,090 aa). Centrosomal protein required in the positioning and anchorage of the microtubule minus-end in epithelial cells. May also act as a centrosome maturation factor. Highest expression in Cells EBV-transformed lymphocytes (59.8 TPM) and Cells Cultured fibroblasts (24.4 TPM).
Seckel syndrome 7 is associated with mutations in the NIN gene on chromosome 14.
NIN is classified as a druggable target (Clinically Actionable category) with score 0.0.
Genetic testing for NIN is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 18 always present features, 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Seckel syndrome 7.
5 publications have been identified in PubMed for Seckel syndrome 7. Research spans Basic Science / Preclinical (60%) and Case Report / Case Series (40%).
Zamanian Najafabadi S (2025). [PMID: 40751525](https://pubmed.ncbi.nlm.nih.gov/40751525/). *Arch Iran Med*. [Case Report / Case Series]
Hudson JJR (2025). [PMID: 40903580](https://pubmed.ncbi.nlm.nih.gov/40903580/). *Nature*. [Basic Science / Preclinical]
Jurca AD (2024). [PMID: 39597091](https://pubmed.ncbi.nlm.nih.gov/39597091/). *Medicina (Kaunas)*. [Case Report / Case Series]
Gilbert T (2024). [PMID: 38836552](https://pubmed.ncbi.nlm.nih.gov/38836552/). *Elife*. [Basic Science / Preclinical]
Tillery MML (2024). [PMID: 39024292](https://pubmed.ncbi.nlm.nih.gov/39024292/). *Mol Biol Cell*. [Basic Science / Preclinical]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 1:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Seckel syndrome 7
Growth and development
2 |
Severe short stature, Intrauterine growth retardation |
Bones and joints | 2 | Delayed skeletal maturation, Lumbar scoliosis |
Arms and legs | 2 | Short middle phalanx of the 5th finger, Clinodactyly of the 5th finger |
Hormones | 2 | Central hypothyroidism, Primary amenorrhea |
Head and neck | 1 | Microcephaly |
Age of onset: childhood.